A serotonergic system in veins: Serotonin transporter-independent uptake

Journal of Pharmacology and Experimental Therapeutics

Volumn 325, Issue 3, 2008, Pages 714-722

  Linder, A Elizabeth ^a   Ni, Wei ^a   Szasz, Theodora ^a   Burnett, Robert ^a   Diaz, Jessica ^a   Geddes, Timothy J ^b   Kuhn, Donald M ^b   Watts, Stephanie W ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; 5 HYDROXYTRYPTOPHAN; MONOAMINE OXIDASE A INHIBITOR; PARGYLINE; SEROTONIN; SEROTONIN TRANSPORTER; TRYPTOPHAN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA; ARTERY; ARTICLE; CAROTID ARTERY; CAVA VEIN; CONTROLLED STUDY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNOHISTOCHEMISTRY; JUGULAR VEIN; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RAT; SEROTONIN METABOLISM; SEROTONIN UPTAKE; SEROTONINERGIC SYSTEM; VEIN; WESTERN BLOTTING; WILD TYPE;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; AORTA; CAROTID ARTERIES; HYDROXYINDOLEACETIC ACID; INTESTINAL MUCOSA; JUGULAR VEINS; MALE; MONOAMINE OXIDASE; RATS; RATS, SPRAGUE-DAWLEY; RATS, WISTAR; RNA, MESSENGER; SEROTONIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; TRYPTOPHAN HYDROXYLASE; VENAE CAVAE;

EID: 44249124238     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.107.135699     Document Type: Article

References (34)

1. Amstein R, Fetkovska N, and Buhler FR (1991) Platelet serotonin-LDL interaction in essential hypertension. J Cardiovasc Pharmacol Ther 17(Suppl 5):S35-S40.
2. Bian X, Patel B, Dai X, Galligan JJ, and Swain G (2007) High mucosal serotonin availability in neonatal guinea pig ileum is associated with low serotonin transporter expression. Gastroenterology 132:2438-2447.
3. Brenner B, Harney JT, Ahmed BA, Jeffus BC, Unal R, Mehta JL, and Kilic F (2007) Plasma serotonin levels and the platelet serotonin transporter. J Neurochem 102:206-215.
4. Chanrion B, Mannoury la Cour C, Bertaso F, Lerner-Natoli M, Freissmuth M, Millan MJ, Bockaert J, and Marin P (2007) Physical interaction between the serotonin transporter and neuronal nitric oxide synthase underlies reciprocal modulation of their activity. Proc Natl Acad Sci U S A 104:8119-8124.
5. Cohen ML, Schenck KW, and Hemrick-Luecke SH (1999) 5- Hydroxytryptamine(1A) receptor activation enhances norepinephrine release from nerves in the rabbit saphenous vein. J Pharmacol Exp Ther 290:1195-1201.
6. Cushing DJ, Baez M, Kursar JD, Schenck K, and Cohen ML (1994) Serotonin-induced contraction in canine coronary artery and saphenous vein: role of a 5-HT1D-like receptor. Life Sci 54:1671-1680.
7. Erspamer V and Asero B (1952) Identification of enteramine, the specific hormone of the enterochromaffin cell system, as 5-hydroxytryptamine. Nature 169:800-801.
8. Fink GD, Johnson RJ, and Galligan JJ (2000) Mechanisms of increased venous smooth muscle tone in desoxycorticosterone acetate-salt hypertension. Hypertension 35:464-469.
9. Gordon J and Barnes NM (2003) Lymphocytes transport serotonin and dopamine: agony or ecstasy? Trends Immunol 24:438-443.
10. Gu H, Wall SC, and Rudnick G (1994) Stable expression of biogenic amine transporters reveals differences in inhibitor sensitivity, kinetics, and ion dependence. J Biol Chem 269:7124-7130.
11. Homberg J, Mudde J, Braam B, Ellenbroek B, Cuppen E, and Joles JA (2006) Blood pressure in mutant rats lacking the 5-hydroxytryptamine transporter. Hypertension 48:e115-e116.
12. Homberg JR, Olivier JD, Smits BM, Mul JD, Mudde J, Verheul M, Nieuwenhuizen OF, Cools AR, Ronken E, Cremers T, et al. (2007) Characterization of the serotonin transporter knockout rat: a selective change in the functioning of the serotonergic system. Neuroscience 146:1662-1676.
13. Horvath G, Sutto Z, Torbati A, Conner GE, Salathe M, and Wanner A (2003) Norepinephrine transport by the extraneuronal monoamine transporter in human bronchial arterial smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 285:L829-L837.
14. Johansen PA, Jennings I, Cotton RG, and Kuhn DM (1995) Tryptophan hydroxylase is phosphorylated by protein kinase A. J Neurochem 65:882-888.
15. Lee SL, Wang WW, and Fanburg BL (2001) Dexfenfluramine as a mitogen signal via the formation of superoxide anion. FASEB J 15:1324-1325.
16. Linder AE, Diaz J, Ni W, Szasz T, Burnett R, and Watts SW (2008) Vascular reactivity, 5-HT uptake and blood pressure in the serotonin transporter knockout rat. Am J Physiol Heart Circ Physiol, in press.
17. Linder AE, Ni W, Diaz JL, Szasz T, Burnett R, and Watts SW (2007) Serotonin (5-HT) in veins: not all in vain. J Pharmacol Exp Ther 323:415-421.
18. Lowry OH, Rosebrough NJ, Farr AL, and Randall RJ (1951) Protein measurement with Folin phenol reagent. J Biol Chem 193:265-267.
19. Marcos E, Adnot S, Pham MH, Nosjean A, Raffestin B, Hamon M, and Eddahibi S (2003) Serotonin transporter inhibitors protect against hypoxic pulmonary hypertension. Am J Respir Crit Care Med 168:487-493.
20. Martel F and Azevedo I (2003) An update on the extraneuronal monoamine transporter (EMT): characteristics, distribution and regulation. Curr Drug Metab 4:313-318.
21. Mekontso-Dessap A, Brouri F, Pascal O, Lechat P, Hanoun N, Lanfumey L, Seif I, Benhaiem-Sigaux N, Kirsch M, Hamon M, et al. (2006) Deficiency of the 5-hydroxytryptamine transporter gene leads to cardiac fibrosis and valvulopathy in mice. Circulation 113:81-89.
22. Ni W, Lookingland K, and Watts SW (2006) Arterial 5-hydroxytryptamine transporter function is impaired in deoxycorticosterone acetate and Nω-nitro-L-arginine but not spontaneously hypertensive rats. Hypertension 48:134-140.
23. Ni W, Thompson JM, Northcott CA, Lookingland K, and Watts SW (2004) The serotonin transporter is present and functional in peripheral arterial smooth muscle. J Cardiovasc Pharmacol 43:770-781.
24. Nilsson O, Ericson LE, Dahlstrom A, Ekholm R, Steinbusch HW, and Ahlman H (1985) Subcellular localization of serotonin immunoreactivity in rat enterochromaffin cells. Histochemistry 82:351-355.
25. Rapport MM, Green AA, and Page IH (1948) Crystalline serotonin. Science 108:329-330.
26. Rozen S and Skaletsky HJ (2000) Primer3 on the WWW for general users and for biologist programmers, in Bioinformatics Methods and Protocols: Methods in Molecular Biology (Kravetz S and Misener S eds) Humana Press, Totowa, NJ.
27. Szasz T, Thakali K, Fink GD, and Watts SW (2007) A comparison of arteries and veins in oxidative stress: producers, destroyers, function, and disease. Exp Biol Med (Maywood) 232:27-37.
28. Thakali K, Galligan JJ, Fink GD, and Watts SW (2007) Arterial and venous function in hypertension., in Comprehensive Hypertension (Gregory YH and Lip JEH eds), Mosby Elsevier, Philadelphia, PA.
29. Vanhoutte PM (1991) Platelet-derived serotonin, the endothelium, and cardiovascular disease. J Cardiovasc Pharmacol 17 (Suppl 5):S6-S12.
30. Wacker MJ and Godard MP (2005) Analysis of one-step and two-step real-time RT-PCR using SuperScript III. J Biomol Tech 16:266-271.
31. Walther DJ, Peter JU, Winter S, Holtje M, Paulmann N, Grohmann M, Vowinckel J, Alamo-Bethencourt V, Wilhelm CS, Ahnert-Hilger G, et al. (2003) Serotonylation of small GTPases is a signal transduction pathway that triggers platelet alpha-granule release. Cell 115:851-862.
32. Watts SW (2005) 5-HT in systemic hypertension: foe, friend or fantasy? Clin Sci (Lond) 108:399-412.
33. Watts SW and Cohen ML (1999) Vascular 5-HT receptors: pharmacology and pathophysiology of 5-HT1B, 5-HT1D, 5-HT1F, 5-HT2B and 5-HT7 receptors. Neurotransmissions 15:3-15.
34. Yamamoto J, Trippodo NC, Ishise S, and Frohlich ED (1980) Total vascular pressure-volume relationship in the conscious rat. Am J Physiol 238:H823-H828.